US stocks close mixed as traders weigh vaccine progress against disappointing jobs data

Business Insider

Published

**

· *US stocks closed mixed on Wednesday as investors weighed COVID-19 vaccine progress against a spike in national virus cases.*
· *A potential vaccine being developed by Pfizer and BioNTech spurred immune responses in healthy patients, Stat News reported Wednesday.*
· *On the economic data front, payroll additions for...

Full Article